Abstract Pyrrolidone-5,5-diphosphonic acids having the formula ##STR1## wherein R is a member selected from the group consisting of hydrogen and alkyl having from 1 to 6 carbon atoms; as well as their water-soluble salts. The pyrrolidone-5,5-diphosphonic acids are excellent sequestering agents especially for alkaline earth metal ions. They are stabilizers for percompounds and are useful in the delaying of the setting times for gypsum. In addition, the compounds are useful as cosmetic preparations such as toothpastes and mouthwashes where they prevent formation of tartar and plaque and are useful in therapy in the treatment of diseases related to the abnormal deposition or dissolution of difficultly soluble calcium salts in the animal body.
A method for alleviating conditions caused by the abnormal deposition or dissolution of difficultly soluble calcium salts in the body of warm-blooded animals having said condition, which consists in administering to said warm-blooded animals a safe but effective amount for said treatment of from 0.05 to 500 mg per kg. of body weight of at least one pharmacologically acceptable pyrrolidone-5,5-diphosphonic acid compound selected from the group consisting of (A) a compound of the formula: ##STR14## wherein R represents hydrogen and alkyl having 1 to 6 carbon atoms, and (B) non-toxic, pharmaceutically acceptable salts thereof.
Claim 2
Independent Claim
94 words
A method for alleviating conditions caused by the abnormal deposition or dissolution of difficultly soluble calcium salts in the body of warm-blooded animals having said condition, which consists in administering to said warm-blooded animals a safe but effective amount for said treatment of from 0.05 to 500 mg per kg. of body weight of at least one pharmacologically acceptable pyrrolidone-5,5-diphosphonic acid compound selected from the group consisting of (A) a compound of the formula: ##STR14## wherein R represents hydrogen and alkyl having 1 to 6 carbon atoms, and (B) non-toxic, pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
9 words
The method of claim 1 wherein R is hydrogen.
Claim 4
Dependent Claim
9 words
The method of claim 1 wherein R is methyl.
Claim 5
Dependent Claim
9 words
The method of claim 1 wherein R is ethyl.
Claim 6
Dependent Claim
9 words
The method of claim 1 wherein R is butyl.
Claim 7
Dependent Claim
12 words
A method according to claim 1 wherein the compound is administered orally.
Claim 8
Dependent Claim
14 words
A method according to claim 1 wherein the compound is administered as a tablet.